Updates are available Correction dated 2023-04-21
Click to view Correction: https://doi.org/10.1186/s13059-023-02944-7
-
Authors
Li, Yun
Huang, Zheng
Zhang, Zhaojun
Wang, Qifei
Li, Fengxian
Wang, Shufang
Ji, Xin
Shu, Shaokun
Fang, Xiangdong
Jiang, Lan https://orcid.org/0000-0003-2008-9631
-
Funding
Funding for this research was provided by:
Strategic Priority Research Program of the Chinese Academy of Sciences (XDB38020500, XDA16010602)
National Key Research and Development Program of China (2019YFA0801702)
National Natural Science Foundation of China (31970760, 82070114, 81870097, 32071117)
International Partnership Program of the Chinese Academy of Sciences (153F11KYSB20210006)
- License Information
-
More Information
Article History
Received: 31 March 2022
Accepted: 1 March 2023
First Online: 6 April 2023
Change Date: 21 April 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13059-023-02944-7
Declarations
:
: The study was approved by the Ethics Committee of Chinese PLA General Hospital (S2022-643–01) and was conducted following the Declaration of Helsinki. All the patients in this study have provided written informed consent.
: L. J. and Y.L. are inventors of a patent application describing the FIPRESCI method. The other authors declare that they have no competing interests. The patent does not restrict the use of the method for educational, research, or not-for-profit purposes.
